
Shiven B. Patel, MD, MBA, shares strategies for closing biomarker testing gaps, including for patients with non–small cell lung cancer.

Shiven B. Patel, MD, MBA, is the head of the thoracic oncology program at Huntsman Cancer Institute, leading both the clinical program and the clinical trials program as it relates to thoracic oncology.

Shiven B. Patel, MD, MBA, shares strategies for closing biomarker testing gaps, including for patients with non–small cell lung cancer.

Shiven B. Patel, MD, MBA, discussed strategies for overcoming tissue limits, delays, and rural access gaps in NSCLC biomarker testing at an IVBM event.

September 14th 2026